0000899243-23-000978.txt : 20230105 0000899243-23-000978.hdr.sgml : 20230105 20230105161014 ACCESSION NUMBER: 0000899243-23-000978 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meury William CENTRAL INDEX KEY: 0001536778 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 23511380 MAIL ADDRESS: STREET 1: C/O FOREST LABORATORIES, INC. STREET 2: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001771917 Karuna Therapeutics, Inc. KRTX 0001536778 Meury William C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, FLOOR 26 BOSTON MA 02110 1 1 0 0 President and CEO Common Stock 2023-01-03 4 A 0 38073 0.00 A 38073 D Stock Option (Right to Buy) 193.19 2023-01-03 4 A 0 63065 0.00 A 2033-01-02 Common Stock 63065 63065 D Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on January 3, 2024, subject to continued service through such dates. 25% of this option shall vest on January 3, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates. /s/ Troy Ignelzi, Attorney-in-Fact 2023-01-05